Home Menu

Site Navigation



Parkinson's Disease Tulip


advertisement
NeuroTalk Support Groups > > >

GDNF therapy looks promising

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 07-12-2016, 01:36 PM #8
imark3000 imark3000 is offline
Member
  
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
15 yr Member
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
15 yr Member
Mad Sure!!!!
Quote:
Originally Posted by soccertese View Post
Sure!!!!
__________________
Imad
Born in 1943. Diagnosed with PD in 2006.
imark3000 is offline   Reply With QuoteReply With Quote
 

Tags
gdnf, promising, therapy

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Brainsway TMS therapy looks quite promising for PD zanpar321 Parkinson's Disease 0 12-16-2014 12:40 PM
New Therapy Promising For MS Patients. SallyC Multiple Sclerosis 1 06-22-2013 08:11 AM
GDNF therapy ti begin Phase I trials in PD olsen Parkinson's Disease 0 11-15-2012 10:32 AM
is it possible to have the GDNF therapy put on the stock market? lou_lou Parkinson's Disease 1 04-05-2010 04:12 PM
GDNF Gene Therapy Trial paula_w Parkinson's Disease 14 03-25-2009 03:44 PM


All times are GMT -5. The time now is 12:19 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home